Mixed treatment for same‐severe mixed urinary incontinence: A novel method

Author:

Hamidi Alamdari Daryoush1,Douzandeh Armina2,Keshvari Shirvan Maliheh3,Narouie Behzad4,Radpour Negar5ORCID

Affiliation:

1. Vascular and Endovascular Surgery Research Center Mashhad University of Medical Sciences Mashhad Iran

2. Department of Health and Biomedicine Victoria University Melbourne Victoria Australia

3. Department of Urology Imam Reza Academic Hospital, Mashhad University of Medical Sciences Mashhad Iran

4. Department of Urology Zahedan University of Medical Sciences Zahedan Iran

5. Urology and Nephrology Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

Abstract

Key Clinical MessageInnovative mixed treatment offers hope for persistent mixed urinary incontinence (MUI): PRP‐Fibrin Glue‐Stem Cell injection, Botox, and TVT in a single session. Successful case study reveals promising outcomes, emphasizing the need for further research.AbstractMixed urinary incontinence is a complaint of stress and urge incontinence which affects patients' quality of life and dramatic changes in patients' physical, mental, and socioeconomic status. The treatment is challenging and depends on the dominance of one of the complaints to the other. The progress in the method of treatment is still under discussion. This study reports treatment of a MUI case in a 56‐year‐old, with a history of MUI of 7‐year duration, which was persistent to pharmacological treatment, pelvic muscle training, biofeedback, and anti‐incontinence surgery (Burch Colposuspension). PRP‐Fibrin Glue‐Stem Cell injection, Botox injection, and TVT were performed in a one surgery session. Patient was discharged with ability to urinate with acceptable amount of post void residue. After 3‐month follow‐up, patient was completely satisfied and happy. Further research is needed to substantiate the efficacy of these mixed treatments for MUI.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3